DeepCare Announces New Funding Round Led by Ananda Investment with Participation from Prudence Holdings and Dr. Wang Xiaochuan

VCBeat has learned that Beijing Feather Medical Cabbage Information Technology Co., Ltd. (DeepCare) has completed a new round of financing, with investors including Annude Investment, Shuimu Investment, and Dr. Wang Xiaochuan, founder of Sogou. Annude Investment served as the lead investor in this round. The funds will be used for the research and development of AI-powered dental products, team building, and international promotion.

DeepCare is a globally leading healthcare technology company specializing in AI applications for dentistry. Its R&D team brings together elite computer scientists and dental medicine experts from prestigious institutions worldwide, including Dartmouth College, the University of California, Los Angeles (UCLA), the University of Maryland, Tsinghua University, Peking University, and Zhejiang University. By integrating cutting-edge artificial intelligence technologies with clinical dental care scenarios, the team has developed innovative AI-powered dental products.

(Left: Dr. Ding Peng, Founder and CEO; Right: Dr. Bai Hailong, Co-founder and CTO)

It is reported that DeepCare’s products are built on proprietary deep learning algorithms meticulously optimized for dental applications. The algorithm was trained on a self-constructed, ultra-large-scale multimodal and cross-regional dental imaging dataset, which was annotated, cross-validated, and reviewed by experienced dental specialists. DeepCare collaborates with top-tier research and commercial institutions, including Peking University School of Stomatology, Shuangbai Investment, and the Straumann Group, to jointly explore the forefront of intelligent dental healthcare.

Sun Yugeng, Investment Director at Annide, stated, “The dental industry is characterized by high disease prevalence, low consultation rates, a scarcity of high-quality dentists, and uneven standards of care. DeepCare leverages artificial intelligence to deliver breakthrough solutions for dental healthcare. Through years of dedicated accumulation and refinement, the team has meticulously crafted a comprehensive product suite that covers the entire workflow—from diagnosis and communication to treatment and data management. This system provides patients with a transparent and clear medical experience, enhances doctor-patient communication efficiency for clinicians, and supports standardized management for dental institutions. Annide is committed to helping DeepCare become the undisputed leader in applying artificial intelligence to oral health.”

Hu Jiezhang, Partner at Shuangbai Investment, stated: “DeepCare is deeply committed to integrating and innovating artificial intelligence with dental care scenarios. It is a sci-tech enterprise characterized by specialization, refinement, uniqueness, and innovation—qualities that Shuangbai Investment has consistently valued and supported. Shuangbai will share its analysis of industry trends and insights into application scenarios, and connect DeepCare with its global resource network spanning imaging, implants, prosthodontics, orthodontics, digitalization, and distribution channels. This support aims to facilitate DeepCare’s implementation within the global dental industry and accelerate its growth into a global leader in dental technology.”

Dr. Wang Xiaochuan, founder of Sogou, has expressed high recognition for DeepCare’s founding team: “This is a radiant team, driven by love and reverence for the world, faith in artificial intelligence, and filled with curiosity and perseverance. I am willing to support such young people in helping us change the world.”

“We are providing next-generation infrastructure for the global dental industry—new infrastructure built on artificial intelligence technology,” said Dr. Ding Peng, Founder and CEO of DeepCare. “Data, information, and intelligence are the key elements of this new infrastructure. Intelligent products will connect, integrate, and drive the entire industry, giving rise to new models and even new business formats. They will undoubtedly be the fundamental driving force behind the next golden decade of development in the dental industry.”

Dr. Bai Hailong, Co-founder and CTO, added, “R&D capability is the core driver of our company. Through sustained increases in R&D investment, we continuously innovate intelligent dental products and lead the intelligent development of the dental industry. In 2020, we completed the AI-based analysis function for panoramic dental radiography, which attracted widespread market attention. This year and next, we will gradually launch multimodal AI analysis products for dental images and data, integrating all functionalities into a single intelligent system. By 2025, we will complete the construction of an AI-driven dental analytics platform, providing intelligent services at every stage of the patient journey—including screening, assisted diagnosis, treatment planning recommendations, treatment outcome assessment, prognosis prediction, and patient follow-up—thereby delivering intelligent services to dental patients worldwide.”

“Innovation is destined to be a journey filled with endless joy and challenges. Only through long-term focus and dedication can we reach the uncharted peaks; only through relentless refinement of our products can we realize our grand visions; and only by persistently doing what is difficult yet right can we reveal the intelligent future that awaits the oral care industry,” remarked Dr. Ding Peng. “Our team is deeply honored to have gained the recognition and support of Anding Capital, Songbo Investment, and Dr. Wang Xiaochuan. With vast mountains and seas ahead, we press forward toward new horizons.”

Annide Partners (hereinafter referred to as “Annide”) is a top-tier global investment institution managing over USD 30 billion in assets for institutional clients worldwide. Its client base includes government funds, pension funds, endowments, insurance companies, and multinational corporations, with investment coverage spanning both primary and secondary markets globally. Upholding an entrepreneurial spirit and guided by value investing principles, Annide adheres to a long-term investment philosophy, seeking out the most promising investment opportunities worldwide. With “Innovative China” as its core theme, Annide has strategically laid out investments in sectors such as artificial intelligence, healthcare, and high-end manufacturing, empowering companies to become internationally recognized industry leaders.

Shuangbai Investment is a long-term investor focused on the global dental industry, committed to becoming a builder of the dental discipline and industry. It provides a stable, long-term development platform for dental professionals and enterprises, understands the vision of dental practitioners, and addresses pain points across the entire upstream, midstream, and downstream industrial chain, with a particular focus on technological R&D, medical education, and information technology. In the field of technological R&D, Shuangbai boasts world-leading management teams and R&D capabilities in clear aligners, dental implants, bone regeneration, imaging, intraoral scanning, and restoration. Its controlled subsidiaries include Angelalign, Purgo Biologics, and Neoss Implant Systems, while its equity investments include Carestream Dental, Aidite, Pingtai Technology, and DeepCare. Strategic partners include Germany’s BEGO and South Korea’s Medit, among others. Since its establishment, Shuangbai Investment has empowered more than 50 companies across the entire dental industry chain, covering major regions such as Asia, the Americas, and Europe.